Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QNCX Quince Therapeutics, Inc.

未开盘 08-20 16:00:00 EDT

32.11

-2.46

-7.12%

盘后32.11

+0.000.00%

19:32 EDT

最高35.15	最低31.62	成交量2.33万
今开34.57	昨收34.57	日振幅10.21%
总市值3,266万	流通市值2,762万	总股本101.71万
成交额79.04万	换手率2.71%	流通股本86.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QNCX","market":"US","secType":"STK","nameCN":"Quince Therapeutics, Inc.","latestPrice":32.11,"timestamp":1787256000000,"preClose":34.57,"halted":0,"volume":23332,"hourTrading":{"tag":"盘后","latestPrice":32.11,"preClose":32.11,"latestTime":"19:32 EDT","volume":150,"amount":4803.37,"timestamp":1787268762287,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07115996528782184,"floatShares":860300,"shares":1017099,"eps":-90.925,"marketStatus":"未开盘","change":-2.46,"latestTime":"08-20 16:00:00 EDT","open":34.57,"high":35.15,"low":31.62,"amount":790373.71654,"amplitude":0.102112,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-90.925,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787299200000},"marketStatusCode":0,"adr":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":34.57,"preHourTrading":{"tag":"盘前","latestPrice":30.3616,"preClose":34.57,"latestTime":"08:34 EDT","volume":113,"amount":3864.4384099999997,"timestamp":1787229253399,"change":-4.2084,"changeRate":-0.121736,"amplitude":0.13186},"postHourTrading":{"tag":"盘后","latestPrice":32.11,"preClose":32.11,"latestTime":"19:32 EDT","volume":150,"amount":4803.37,"timestamp":1787268762287,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.769099,"impliedVol":2.224,"impliedVolPercentile":0.6273},"requestUrl":"/m/hq/s/QNCX","defaultTab":"news","newsList":[{"id":"1195724669","title":"Quince Therapeutics：Leerink Partners因应1拆20并股调整目标价至68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195724669","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195724669?lang=zh_cn&edition=full","pubTime":"2026-08-18 18:54","pubTimestamp":1787050450,"startTime":"0","endTime":"0","summary":"Quince Therapeutics——Leerink Partners的分析师近日发布报告，将该公司目标股价由此前的4美元大幅上调至68美元。此番调整，主要源于公司实施的1股拆分为20股的反向股票分割操作。具体来看，这家投资机构在最新研究纪要中指出，考虑到Quince Therapeutics已完成股份合并，其股价评估模型需相应修正。Leerink Partners的此次调整，本质上是对既有估值进行数学换算，以确保目标价格与当前股本结构保持一致。对于关注Quince Therapeutics的投资者而言，这一信息有助于更准确地理解当前股价的参考基准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136629430","title":"Quince Therapeutics 任命 Brigette Roberts 为首席执行官，条件性生效 - SEC 文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1136629430","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136629430?lang=zh_cn&edition=full","pubTime":"2026-08-01 04:53","pubTimestamp":1785531190,"startTime":"0","endTime":"0","summary":"Quince Therapeutics 公司近日通过提交给美国证券交易委员会（SEC）的文件披露，已条件性任命 Brigette Roberts 为首席执行官。这一高层人事变动标志着公司治理结构进入新阶段。Roberts 的任命附有特定条件，具体细节在官方文件中有所载明。当前，这家生物制药企业正致力于推进其核心研发管线，新领导层的到来或将为其战略方向带来深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152261255","title":"Quince宣布收购Orphai并拟通过至多1.87亿美元私募融资推进肺部疾病管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1152261255","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152261255?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:28","pubTimestamp":1779110937,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc. 已宣布将收购生物技术公司Orphai，并计划通过至多1.87亿美元的私募股权融资来支持其肺部疾病治疗管线的开发。此项交易旨在整合资源，加速相关疗法的研究进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176907595","title":"Quince 公司 Lam-001 二期a阶段试验：特发性肺纤维化患者24周时6分钟步行距离改善6740万米，肺血管阻力降低33.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176907595","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176907595?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:27","pubTimestamp":1779110835,"startTime":"0","endTime":"0","summary":"Quince Therapeutics 公司宣布，其候选药物 Lam-001 在针对特发性肺纤维化（Ph-ILD）患者的二期a阶段临床试验中取得了积极结果。数据显示，治疗24周后，患者的六分钟步行距离（6MWD）实现了6740万米的显著改善，同时肺血管阻力（PVR）也降低了33.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189218505","title":"Quince Therapeutics公布PAH与PH-ILD二期研究结果：功能、血流动力学及生物标志物指标均呈现具临床意义的改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1189218505","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189218505?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:27","pubTimestamp":1779110834,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc. 近日宣布，其针对肺动脉高压（PAH）及肺动脉高压相关性间质性肺病（PH-ILD）的二期临床研究取得了积极成果。数据显示，在功能评估、血流动力学参数以及关键生物标志物等多个核心测量指标上，均观察到了具有临床意义的显著改善。这一进展为后续的临床开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120579970","title":"Quince完成5亿美元E轮融资，估值达101亿美元加速制造商直达消费者平台发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1120579970","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120579970?lang=zh_cn&edition=full","pubTime":"2026-03-11 18:02","pubTimestamp":1773223321,"startTime":"0","endTime":"0","summary":"Quince近日成功完成5亿美元E轮融资，公司估值飙升至101亿美元。本轮融资将用于加速其制造商直达消费者（M2C）平台的扩张战略，通过优化供应链和数字化技术提升消费体验。该融资成果彰显了资本市场对创新商业模式的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618608064","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618608064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618608064?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:32","pubTimestamp":1773063134,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时32分，Quince Therapeutics, Inc.股票出现异动，股价急速下挫5.08%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Relmada Therapeutics, Inc.、Xenon制药、Dianthus Therapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、Moolec Science Sa、Quince Therapeutics, Inc.较为活跃，换手率分别为30.31%、18.75%、13.16%，振幅较大的相关个股有Aditxt, Inc.、Reviva Pharmaceuticals Holdings, Inc.、Uniqure N.V.，振幅分别为17.03%、13.72%、12.96%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030921321497ab242c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030921321497ab242c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518202735","title":"Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518202735?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:18","pubTimestamp":1741634284,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时18分，Quince Therapeutics, Inc.股票出现波动，股价大幅下跌5.30%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6316.63%、3862.24%、1024.29%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512370483","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512370483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512370483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Quince Therapeutics, Inc.股票出现波动，股价大幅拉升5.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Allogene Therapeutics, Inc.、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为204.04%、202.00%、65.54%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Osr Holdings, Inc.，振幅分别为31.34%、11.29%、10.29%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512660351","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512660351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512660351?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889060,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Quince Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.19%、90.58%、58.67%，振幅较大的相关个股有Allakos Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为6.84%、6.43%、6.13%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511575105","title":"Quince Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511575105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511575105?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:14","pubTimestamp":1739470443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时14分，Quince Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报1.47美元/股，成交量9.5076万股，换手率0.22%，振幅6.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510986161","title":"Quince Therapeutics, Inc.盘中异动 早盘快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510986161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510986161?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:28","pubTimestamp":1739201329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时28分，Quince Therapeutics, Inc.股票出现波动，股价快速跳水5.41%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2546.55%、1506.14%、953.59%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509676407","title":"D. Boral Capital：维持Quince Therapeutics(QNCX.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509676407","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509676407?lang=zh_cn&edition=full","pubTime":"2025-02-05 20:11","pubTimestamp":1738757515,"startTime":"0","endTime":"0","summary":"D. Boral Capital：维持Quince Therapeutics(QNCX.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05201147968474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["QNCX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505971271","title":"Quince Therapeutics, Inc.股价重挫14.46% 市值跌192.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505971271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505971271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469934,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分，Quince Therapeutics, Inc.股票出现异动，股价快速下挫14.46%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为530.12%、161.41%、28.48%，振幅较大的相关个股有Allakos Inc.、Cellectis Ads Each Repr 1 Ord Spon、Equillium, Inc.，振幅分别为111.05%、107.43%、107.00%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492181805","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492181805?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:32","pubTimestamp":1734532361,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时32分，Quince Therapeutics, Inc.股票出现波动，股价大幅拉升5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1008.78%、299.12%、240.76%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、37.37%、24.76%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490012080","title":"Quince Therapeutics, Inc.盘中异动 早盘快速上涨5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490012080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490012080?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841061,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Quince Therapeutics, Inc.股票出现波动，股价快速拉升5.39%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Chimerix, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1640.08%、398.07%、84.71%，振幅较大的相关个股有Silexion Therapeutics Corp、Glycomimetics, Inc.、Lantern Pharma Inc.，振幅分别为9.70%、8.97%、6.75%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489466354","title":"Quince Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489466354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489466354?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:44","pubTimestamp":1733413498,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时44分，Quince Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2244.15%、1499.46%、389.58%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为109.61%、105.08%、100.06%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488519751","title":"Quince Therapeutics, Inc.盘中异动 早盘急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488519751?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:30","pubTimestamp":1733322647,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时30分，Quince Therapeutics, Inc.股票出现波动，股价急速下挫5.09%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1166.71%、189.27%、109.36%，振幅较大的相关个股有Theratechnologies Inc.、Organovo Holdings, Inc.、Serina Therapeutics, Inc.，振幅分别为6.79%、5.30%、3.70%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485065298","title":"Quince Therapeutics, Inc.2024财年第三财季实现净利润-5.49百万美元，同比减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485065298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485065298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291282,"startTime":"0","endTime":"0","summary":"11月23日，Quince Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-5.49百万美元，同比减少2.62%；其中营业收入为0.00美元，每股基本收益为-0.13美元。机构评级：截至2024年11月23日，当前有3家机构对Quince Therapeutics, Inc.目标价做出预测，其中目标均价为9.67美元，其中最低目标价为6.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484925425","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.71%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484925425?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:54","pubTimestamp":1732028074,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时54分，Quince Therapeutics, Inc.股票出现异动，股价急速上涨5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为680.61%、90.32%、74.97%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.，振幅分别为81.67%、52.14%、45.03%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quincetx.com","stockEarnings":[{"period":"1week","weight":0.1059},{"period":"1month","weight":0.8369},{"period":"3month","weight":0.6154},{"period":"6month","weight":0.1516},{"period":"1year","weight":-0.8926},{"period":"ytd","weight":-0.9484}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家生物技术公司，在完成其3期NEAT试验之前，专注于利用其专有的AIDE技术平台开发罕见病治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.091321},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.101646},{"month":3,"riseRate":0.428571,"avgChangeRate":0.087035},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.03031},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.092353},{"month":6,"riseRate":0.625,"avgChangeRate":0.135399},{"month":7,"riseRate":0.375,"avgChangeRate":-0.03183},{"month":8,"riseRate":0.5,"avgChangeRate":0.088583},{"month":9,"riseRate":0.571429,"avgChangeRate":0.013938},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.049658},{"month":11,"riseRate":0.571429,"avgChangeRate":0.199459},{"month":12,"riseRate":0.285714,"avgChangeRate":0.079276}],"exchange":"NASDAQ","name":"Quince Therapeutics, Inc.","nameEN":"Quince Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Quince Therapeutics, Inc.,QNCX,Quince Therapeutics, Inc.股票,Quince Therapeutics, Inc.股票老虎,Quince Therapeutics, Inc.股票老虎国际,Quince Therapeutics, Inc.行情,Quince Therapeutics, Inc.股票行情,Quince Therapeutics, Inc.股价,Quince Therapeutics, Inc.股市,Quince Therapeutics, Inc.股票价格,Quince Therapeutics, Inc.股票交易,Quince Therapeutics, Inc.股票购买,Quince Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}